In conclusion, we report for the first time that two (rs7897947 and rs12769316) of the three studied genetic variants of the NF-kB2 are associated with increased risk and decreased OS outcome of patients with NSCLC. Here, NFKB2 is linked to non-small cell lung carcinoma.